+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Cattle, Poultry), by Drug Class (Macrolides, Penicillins), by Dosage Form (Oral Solution, Oral Powder), and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2022
  • Region: Europe
  • Grand View Research
  • ID: 5681742
Description Jump to:
The Europe veterinary antibiotics market size is expected to reach USD 1.31 billion by 2030, registering a CAGR of 3.59% over the forecast period. The rising focus on animal-only antibiotics and ionophores, the launch of new products, and the increasing use of veterinary antibiotics are some of the major factors augmenting the industry's growth. In addition, the rising prevalence and incidence of livestock diseases and concerns regarding zoonoses are further propelling the industry's growth. The COVID-19 pandemic has affected the veterinary antibiotic business operations of key players and resulted in declined financial performance during the initial time.

The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, with the easing of restrictions, manufacturers were able to supply antibiotics to meet the necessary veterinary requirements. Few major players have reported significant growth in antibiotic sales despite the pandemic. For instance, Virbac’s bovine antibiotic sales grew from USD 66.98 million in 2020 to USD 79.30 million in 2021. The global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Despite the regulatory changes implemented by the European Medicines Agency (EMA) for restriction and ban on routine antibiotic use, the overall sales of veterinary antimicrobial active ingredients have observed significant growth in the past few years.

For instance, according to the EMA, overall veterinary antimicrobial active substance sales grew from 5,282 tonnes in 2019 to 5,562 tonnes in 2020. Furthermore, major players, such as Elanco, have shifted their focus to animal-only antibiotics, as a measure to address antibiotic resistance while also protecting animal health. Key players are implementing various strategic initiatives, such as mergers, partnerships, acquisitions, collaborations, and new product launches, to maintain their competitive edge. For instance, in December 2021, Virbac, in collaboration with Pharmgate, launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These activities are expected to intensify the competition between major antibiotic manufacturers in the coming years.

Europe Veterinary Antibiotics Market Report Highlights

  • The cattle animal type segment accounted for the largest revenue share in 2021 owing to the easy availability of cattle antibiotics and increased consumption of beef & dairy products
  • By drug class, the penicillin segment held the largest revenue share in 2021. Penicillinis one of the most commonly sold antibiotic drug classes in Europe for veterinary application
  • According to the EMA, the overall sales of veterinary penicillin accounted for 31.1% in 2020
  • The oral solution segment led the market in 2021 owing to the easy & convenient usage of these dosage forms. These solutions are preferably dispensed in the drinking water
  • The U.K. accounted for the largest revenue share in 2021 and Poland is expected to grow at the fastest CAGR from 2022 to 2030
  • Key factors contributing to the notable share of the U.K. include the easy availability of veterinary antibiotics and an increase in pet ownership & pet insurance rates
  • The industry is fairly competitive owing to the presence of major players. Various strategic initiatives implemented by companies are greatly contributing to the growth of the industry


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Country Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information/Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.7 List Of Secondary Sources
Chapter 2 Executive Summary
2.1 Europe Veterinary Antibiotics Market Outlook
2.1.1 Segment Outlook
2.1.2 Country Outlook
2.1.3 Competitive Outlook
2.2 Europe Veterinary Antibiotics Market Snapshot, 2021
2.3 Overall Estimated Sales Of Antimicrobial Vmps (Active Substance) In Tonnes By Country, In 2019/2020
2.4 Estimated Sales Of Antimicrobial Active Substances By Antimicrobial Class, 2019/2020
Chapter 3 Europe Veterinary Antibiotics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.2 Ancillary Market Analysis
3.2 Penetration And Growth Prospect Mapping
3.3 Europe Veterinary Antibiotics Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Rising Focus On Animal-Only Antibiotics And Ionophores
3.3.1.2 Growing Initiatives By Key Companies Or Launch Of New Products
3.3.1.3 Prudent And Responsible Use Of Antibiotics
3.3.2 Market Restraint Analysis
3.3.2.1 Stringent Regulations
3.3.2.2 Decline In Use Of Antibiotics
3.3.2.3 Active Research On Antibiotic Alternatives
3.3.3 Market Opportunity Analysis
3.3.4 Market Challenge Analysis
3.4 Industry Analysis
3.4.1 Porter’s Analysis
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Threat Of Substitutes
3.4.1.4 Threat Of New Entrants
3.4.1.5 Competitive Rivalry
3.4.2 Pestel Analysis
3.4.2.1 Political & Legal Landscape
3.4.2.2 Economic & Social Landscape
3.4.2.3 Environmental Landscape
3.4.2.4 Technology Landscape
3.5 Regulatory Framework
3.5.1 Dossier Requirements
3.6 Patent-Off Dates Analysis For Major Veterinary Antibiotics
3.7 Product Pipeline Analysis
3.8 COVID-19 Impact Analysis
3.8.1 Current And Future Impact Analysis
3.8.2 Impact On Market Players
Chapter 4 Animal Type Estimates & Trend Analysis, 2017 - 2030 (USD Million)
4.1 Animal Type Movement Analysis, 2017 - 2030 (USD Million)
4.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030
4.3 Pigs
4.3.1 Pigs Market Estimates And Forecasts, 2017 - 2030 (USD Million)
4.4 Cattle
4.4.1 Cattle Market Estimates And Forecasts, 2017 - 2030 (USD Million)
4.5 Sheep & Goats
4.5.1 Sheep & Goats Market Estimates And Forecasts, 2017 - 2030 (USD Million)
4.6 Poultry
4.6.1 Poultry Market Estimates And Forecasts, 2017 - 2030 (USD Million)
4.7 Others
4.7.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 5 Drug Class Estimates & Trend Analysis, 2017 - 2030 (USD Million)
5.1 Drug Class Movement Analysis, 2017 - 2030 (USD Million)
5.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030
5.2.1 Tetracyclines
5.2.1.1 Tetracyclines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.2 Penicillins
5.2.2.1 Penicillins Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.3 Sulfonamides
5.2.3.1 Sulfonamides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.4 Macrolides
5.2.4.1 Macrolides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.5 Trimethoprim
5.2.5.1 Trimethoprim Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.6 Lincosamides
5.2.6.1 Lincosamides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.7 Polymyxins
5.2.7.1 Polymyxins Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.8 Aminoglycosides
5.2.8.1 Aminoglycosides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.9 Fluoroquinolones
5.2.9.1 Fluoroquinolones Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.10 Pleuromutilins
5.2.10.1 Pleuromutilins Market Estimates And Forecasts, 2017 - 2030 (USD Million)
5.2.11 Others
5.2.11.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 6 Dosage Form Estimates & Trend Analysis, 2017 - 2030 (USD Million)
6.1 Dosage Form Movement Analysis, 2017 - 2030 (USD Million)
6.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030
6.2.1 Oral Powder
6.2.1.1 Oral Powder Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.2 Oral Solutions
6.2.2.1 Oral Solutions Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.3 Injections
6.2.3.1 Injection Market Estimates And Forecasts, 2017 - 2030 (USD Million)
6.2.4 Others
6.2.4.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 7 European Countries Estimates & Trend Analysis, 2017 - 2030 (USD Million)
7.1 European Countries Market Share Analysis, 2021 & 2030
7.2 Europe
7.2.1 Europe Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.3 Germany
7.3.1 Germany Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.4 U.K.
7.4.1 U.K. Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.5 France
7.5.1 France Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.6 Italy
7.6.1 Italy Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.7 Spain
7.7.1 Spain Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.8 Belgium
7.8.1 Belgium Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.9 The Netherlands
7.9.1 The Netherlands Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.10 Hungary
7.10.1 Hungary Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.11 Poland
7.11.1 Poland Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.12 Portugal
7.12.1 Portugal Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.13 Romania
7.13.1 Romania Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
7.14 Denmark
7.14.1 Denmark Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 8 Europe Veterinary Antibiotics Market - Competitive Landscape
8.1 Company Profiles
8.1.1 MERCK & CO., INC.
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 CEVA
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 VETOQUINOL S.A.
8.1.3.1 Company overview
8.1.3.2 FINANCIAL PERFORMANCE
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 ZOETIS
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 ELANCO
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 VIRBAC
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 CALIER
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 BIMEDA, INC.
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 PRODIVET PHARMACEUTICALS SA/NV
8.1.10.1 Company overview
8.1.10.2 Product benchmarking
8.2 Market Participation Categorization
8.3 Company Market Position Analysis - Heat Map Analysis
8.4 Synergy Analysis: Major Deals & Strategic Alliances
8.5 List of Key Companies
8.5.1 List Of Manufacturers
8.5.2 List Of Distributors
List of Tables
Table. 1 List of secondary sources
Table. 2 Estimated sales of antimicrobial VMPs (active substance) in tonnes by country, in 2019/2020
Table. 3 Estimated sales of antimicrobial active substances by class, in 31 EU countries, 2019/2020 (tablets excluded)
Table. 4 Estimated sales of antimicrobial active substances by major class, in 31 EU countries, 2020 (only tablets)
Table. 5 EMA antibiotic class categorization for prudent and responsible use
Table. 6 Dossier submission for procedures involving veterinary NAPs to national competent authorities
Table. 7 Zoetis patent-off dates analysis for key veterinary antibiotics
Table. 8 Dechra Pharmaceuticals product pipeline analysis
Table. 9 Norbrook product pipeline analysis
Table. 10 List of Manufacturers
Table. 11 List of Distributors
Table. 12 Europe Veterinary Antibiotics market, by country, 2017-2030 (USD Million)
Table. 13 Europe Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 14 Europe Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 15 Europe Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 16 U.K. Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 17 U.K. Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 18 U.K. Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 19 Germany Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 20 Germany Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 21 Germany Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 22 France Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 23 France Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 24 France Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 25 Italy Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 26 Italy Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 27 Italy Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 28 Spain Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 29 Spain Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 30 Spain Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 31 The Netherlands Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 32 The Netherlands Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 33 The Netherlands Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 34 Belgium Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 35 Belgium Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 36 Belgium Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 37 Denmark Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 38 Denmark Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 39 Denmark Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 40 Hungary Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 41 Hungary Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 42 Hungary Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 43 Poland Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 44 Poland Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 45 Poland Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 46 Portugal Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 47 Portugal Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 48 Portugal Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
Table. 49 Romania Veterinary Antibiotics market, by Animal Type, 2017-2030 (USD Million)
Table. 50 Romania Veterinary Antibiotics market, by Drug Class, 2017-2030 (USD Million)
Table. 51 Romania Veterinary Antibiotics market, by Dosage Form, 2017-2030 (USD Million)
List of Figures
Fig. 1 Europe Veterinary Antibiotics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 General methodology for Commodity flow analysis of Animal Health markets
Fig. 9 Commodity flow analysis
Fig. 10 Europe Veterinary Antibiotics Market Snapshot (2021, USD Million)
Fig. 11 Parent market outlook
Fig. 12 Ancillary market outlook
Fig. 13 Penetration & growth prospect mapping, by dosage form, 2021
Fig. 14 Europe Veterinary Antibiotics market dynamics analysis
Fig. 15 Europe Veterinary Antibiotics market driver analysis
Fig. 16 Europe Veterinary Antibiotics market restraint impact
Fig. 17 Europe veterinary antibiotics market: Animal type movement analysis, 2017-2030 (USD Million)
Fig. 18 Europe veterinary antibiotics market share analysis, 2021 & 2030
Fig. 19 Pigs market, 2017-2030 (USD Million)
Fig. 20 Cattle market, 2017-2030 (USD Million)
Fig. 21 Sheep & goats market, 2017-2030 (USD Million)
Fig. 22 Poultry market, 2017-2030 (USD Million)
Fig. 23 Other Animal Types market, 2017-2030 (USD Million)
Fig. 24 Europe veterinary antibiotics market: Drug class movement analysis, 2017-2030 (USD Million)
Fig. 25 Sales of antimicrobial active substances by class, %, 2020
Fig. 26 Europe veterinary antibiotics market share analysis, 2021 & 2030
Fig. 27 Tetracyclines market, 2017-2030 (USD Million)
Fig. 28 Penicillins market, 2017-2030 (USD Million)
Fig. 29 Sulfonamides market, 2017-2030 (USD Million)
Fig. 30 Macrolides market, 2017-2030 (USD Million)
Fig. 31 Trimethoprim market, 2017-2030 (USD Million)
Fig. 32 Lincosamides market, 2017-2030 (USD Million)
Fig. 33 Polymyxins market, 2017-2030 (USD Million)
Fig. 34 Aminoglycosides market, 2017-2030 (USD Million)
Fig. 35 Fluoroquinolones market, 2017-2030 (USD Million)
Fig. 36 Pleuromutilins market, 2017-2030 (USD Million)
Fig. 37 Other Drug Class market, 2017-2030 (USD Million)
Fig. 38 Europe veterinary antibiotics market: Dosage form movement analysis, 2017-2030 (USD Million)
Fig. 39 Sales of antimicrobial active substances by dosage form, %, 2020
Fig. 40 Europe veterinary antibiotics market share analysis, 2021 & 2030
Fig. 41 Oral powder market, 2017-2030 (USD Million)
Fig. 42 Oral solutions market, 2017-2030 (USD Million)
Fig. 43 Injection market, 2017-2030 (USD Million)
Fig. 44 Other Dosage Forms market, 2017-2030 (USD Million)
Fig. 45 European countries market share analysis, 2021 & 2030
Fig. 46 Europe veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 47 Germany veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 48 U.K. veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 49 France veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 50 Italy veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 51 Spain veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 52 Belgium veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 53 The Netherlands veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 54 Hungary veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 55 Poland veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 56 Portugal veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 57 Romania veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 58 Denmark veterinary antibiotics market, 2017-2030 (USD Million)
Fig. 59 Market participation categorization
Fig. 60 Company market position analysis
Fig. 61 Major deals & strategic alliances analysis

Companies Mentioned

  • Merck & Co. Inc.
  • Ceva
  • Vetoquinol S.A.
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Virbac
  • Calier
  • Bimeda, Inc.
  • Prodivet Pharmaceuticals Sa/Nv

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedOctober 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 0.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.31 Billion
Compound Annual Growth Rate3.5%
Regions CoveredEurope
No. of Companies Mentioned10

Related Topics

Related Reports

Global Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Forecast 2024-2030 - Product Image

Global Veterinary Pharmaceuticals Market by Product (Veterinary Antibiotics, Veterinary Parasiticides, Veterinary Vaccines), Vaccines (Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), Antibiotics, End User, Animal - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Veterinary Antibiotics Global Market Report 2024 - Product Image

Veterinary Antibiotics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Veterinary Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Veterinary Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 86 Pages
  • Global
From
Veterinary Dermatology Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 - Product Image

Veterinary Dermatology Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

  • Report
  • 171 Pages
  • Global
From
Animal Antibiotics and Antimicrobials Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Animal Antibiotics and Antimicrobials Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 182 Pages
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.